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Abstract 
 
Environmental Epigenomics is a developing field to study the epigenetic effect on human 
health from exposure to environmental factors. Endocrine disrupting chemicals have been 
detected primarily in pharmaceutical drugs, personal care products, food additives, and 
food containers. Exposure to endocrine-disrupting chemicals (EDCs) has been associated 
with a high incidence and prevalence of many endocrine-related disorders in humans. 
Nevertheless, further evidence is needed to establish a correlation between exposure to 
EDC and human disorders.  
Conventional detection of EDCs is based on chemical structure and concentration sample 
analysis. However, substantial evidence has emerged, suggesting that cell exposure to 
EDCs leads to epigenetic changes, independently of its chemical structure with non-
monotonic low-dose responses.  
Consequently, a paradigm shift in toxicology assessment of EDCs is proposed based on a 
comprehensive review of analytical techniques used to evaluate the epigenetic effects. 
Fundamental insights reported elsewhere are compared in order to establish DNA 
methylation analysis as a viable method for assessing endocrine disruptors beyond the 
conventional study approach of chemical structure and concentration analysis. 
 
Keywords: Endocrine-disrupting chemicals, monitoring, epigenetic analysis  
1. Introduction  
 
Pharmaceuticals, personal care products, food additives, and plastics, among others, are 
considered essential to modern lifestyle. Nevertheless, many of these chemical compounds 
have been found in unexpected regions. For example, the antiviral medication Tamiflu was 
found in surface waters in United Kingdom (Singer et al., 2007); 17 micropollutants (e.g., 
bisphenol A (BPA), diclofenac, naproxen, di-2-ethylhexylphthalate (DEHP), triclosan, etc.) 
were determined in surface and ground waters in Mexico City (Félix-Cañedo, 2013); and 
even illicit drugs have been found at selected locations of the Colorado Basin in the United 
States (Jones-Lepp et al., 2012). The toxicity data of these molecules are not completely 
available or have not yet been fully investigated. Thus, assessing the impact of these 
molecules on human health has become a pressing need for global agencies and institutes 
aimed at protecting public health and environment care, such as the World Health 
Organization (WHO) and the European Commission (Falconer et al., 2006; Hutchinson et 
al., 2013; Mc Clellan & Halden, 2010). 
 
Some contaminants with particular chemical structures and properties that interfere with 
endocrine systems have been of increasing interest. These endocrine-disrupting chemicals 
(EDCs) are poorly regulated, and information on their environmental impact is currently 
incomplete (Campbell et al., 2006; Kundakovic & Champagne, 2011; Petrovic et al., 
2004). However, preliminary results from in vivo models, and epidemiological and clinical 
studies, have shown that EDCs play a role in diseases such as breast cancer and prostate 
cancer; metabolic diseases such as obesity; and effects on the human reproductive, thyroid, 
cardiovascular, and neuroendocrinology systems. Therefore, it has become a global public 
health issue (Anway et al., 2005: Diamanti-Kandarakis et al., 2009; Gore et al., 2011; 
Kundakovic & Champagne, 2011; Li et al., 1997; Mc Lachlan, 2001; Svechnikov et al., 
2010). 
 
Besides wastewaters, other sources of EDCs related to human activity are present, for 
example, in high-volume horizontal hydraulic fracturing. This new mining technique is 
employed for shale gas extraction, using chemicals known to exert neurotoxic, 
carcinogenic, and endocrine-disrupting effects. The economic implications of natural gas 
extraction have resulted in insufficient investigation into the health implications (Rafferty 
& Limonik, 2013). Furthermore, the information related to nanoparticles and carbon 
nanotubes has raised in the last years (Iavicoli et al., 2013; Lam et al., 2006; Lanone et al., 
2013; Lu et al., 2013; Nel et al., 2006). 
 
Sampling and identification of EDCs in environmental matrices is expensive and time 
consuming. In this regard, the US Environmental Protection Agency (EPA) has proposed 
various methods for EDC screening, considering factors such as persistence, 
bioaccumulation potential, and toxicity (PBT approach). Nevertheless, this strategy has 
been criticized as it overlooks chemical usage rates and real-world biodegradability 
(Venkatesan & Halden, 2014). 
 
Identification of novel substances such as EDCs should be based on their long-term effects 
in organisms and the environment beyond the conventional accumulation, distribution, 
metabolism, or excretion analysis. Epigenetics can lead to a gene expression change in 
response to ambient factors and can inherit potential adverse alterations underlying the 
genome, as reported by Guerrero-Bosagna et al., (2013). Therefore, environmental matrices 
can be measured in terms of general epigenetic activity. Many of the mechanisms by which 
EDCs exert their genotypic and phenotypic effects remain unknown, but there is emerging 
evidence related to epigenetic deregulation. Consequently, efforts related to toxicology and 
safety assessment have focused on epigenetic mechanisms related to exposure to chemical 
compounds in vitro and in vivo (Greally, 2011). In this review, we suggest environmental 
monitoring of EDCs by measuring their epigenetic effects through the analysis of DNA 
methylation. 
 
2. Epigenetics and mechanisms of EDCs 
 
 In 1942, Conrad H. Waddington introduced the epigenetics term and described the 
multiple ways in which epigenetics can regulate gene expression, resulting in a particular 
phenotype. In fact, epigenetics research includes a variety of events, such as messenger 
RNA (mRNA) silencing through microRNAs (miRNAs), chromatin remodeling, histone 
modifications, and DNA methylation. Histone modification and DNA methylation are 
heritable events, but they do not involve DNA changes or mutations (Jaenisch & Bird, 
2003). 
Hormones are known to be signaling molecules capable of modifying gene expression in 
non-mammalian and mammalian vertebrates. The changes in gene expressions could be 
determined by DNA methylation and chromatin modifications (Andres et al., 1984; Anway 
et al., 2005; Edinger et al., 2013). Cellular imprinting by EDCs may be caused by two 
mechanisms: the EDC may imprint the gene either through a process leading to genetic 
change (e.g., DNA methylation) or by altering key steps in cell differentiation signaling 
pathways such that gene expression could form a biochemical memory (McLachlan, 2001). 
In order to understand the process by which EDCs interact and regulate gene expression, it 
is important to note that genes are not expressed alone but rather in the context of other 
genes and their products, cells, and tissues in a temporal/spatial dimension (Crews & 
McLachlan, 2006). If an external stimulus like an emerging contaminant alters endogenous 
hormone secretion or sensitivity of tissues, then alternative development pathways could be 
present due to these endocrine interactions (Nijhout, 2003). 
EDCs affect the anatomical development and histological organization of male and female 
reproductive structures, resulting in fertility issues, as well as cancer of the female 
reproductive tract. Therefore, it is logical to assume that EDCs act by interacting with the 
respective sex hormone receptors (Bernal & Jirtle, 2010; Gore et al., 2011; Guerrero-
Bosagna et al., 2013; Knower et al., 2014; Svechnikov et al., 2010; Uzumcu et al., 2012). 
The interaction of EDCs with sex hormone receptors can trigger signaling pathways that 
generate epigenetic changes in DNA methylation, which may be heritable, resulting in gene 
expression changes without DNA sequence mutations (Alworth, 2002; Anway et al., 2005; 
Kundakovic & Champagne, 2011; Li et al., 1997). Epigenetic changes involved in cell 
differentiation in affected tissues are common, which were first demonstrated by Li et al. in 
1997. The authors discovered that upon exposure to a synthetic estrogen, diethylstilbestrol 
(DES), female mice showed an altered pattern of CpG methylation in the lactotransferrin 
gene promoter region in the uterus. Specifically, an abnormal demethylation of a CpG 
island occurs in response to neonatal DES exposure and adult ovarian hormones. These 
experiments led to the hypothesis that DES, and other environmental estrogens, can alter 
the estrogen-mediated differentiation of reproductive tract target cells, that is, an epigenetic 
mechanism. Furthermore, in gestating female rats, Anway et al. (2005) demonstrated that 
transient exposure to EDCs such as vinclozolin (antiandrogenic compound) or 
methoxychlor (estrogenic compound) of during the gonadal sex determination period 
induced a decrease in spermatozoid viability and cell number in the first-generation adult 
phenotype, thus male infertility increase. The decrease in spermatogenic production was 
inherited through four subsequent male generations. Moreover, abnormalities during 
pregnancy such as anemia, preeclampsia, and blood cell defects, were observed. Although, 
sexual differentiation effects and infertility have been correlated with DNA methylation 
changes, no evidence of the role of specific genes in these events was reported. 
Nevertheless, the whole genome effect has been elucidated. Epigenomic changes caused by 
EDCs might lead to transgenerational inheritance due to their wide distribution and the 
stability of target cells (Greally, 2011). 
Other epigenetic mechanisms involve molecular regulators such as histone variant, histone 
post-translational modifications, nucleosome positioning chromosome looping, DNA 
structural variations, and RNA-mediated regulation (Beiter et al., 2009; Bernstein et al., 
2007; Gibney & Nolan, 2010; Hartley & Madhani, 2009; Hiragrami-Hamada et al., 2009; 
Jia et al., 2007; Klose & Bird, 2006). These mechanisms are closely related to chromatin 
conformation and, therefore, polymerase accessibility for gene expression. Studies have 
suggested an ordered pathway for chromatin architecture conformation, because 
nucleosome positioning requires histone deposition and sequences such as nucleosome-free 
regions (NFRs) (Hartley & Madhani, 2009).  
Regarding genetic regulation mediated by histone modifications, Hiragami-Hamada et al. 
(2009) demonstrated that gene silencing was associated with histone H3 trimethylation at 
lysine 9 (H3K9me3) in an animal model. They also showed that histone H3 acetylation at 
lysine 4 and di- or tri-lysine methylation (H3K4me2/3) were very common modifications 
related to changes in gene expression. These and other histone modifications were 
associated with transcription regulation; however, no known histone code was related to the 
regulation processes mediated by hormones, and neither were these modifications 
associated with EDCs. 
The study of miRNAs as epigenetic regulators of gene expression has expanded 
significantly in recent decades, although it remains a developing area, because a single 
miRNA can have several target mRNAs and can be regulated by different miRNAs (Klein 
et al., 2005; Kosik, 2006; Zhang & Ho, 2014). Several predictive software to determine 
putative targets of different miRNAs are available, but the generation rate of false positives 
is still high; thus, experimental evidence is necessary (Wang & Wang, 2006). Experimental 
findings have shown a relationship between miRNA activity and the respective targets. 
However, cells show different types of epigenetic regulation depending on the cell 
environment and stimulus received. In addition, it has been observed that the regulation 
process is related to tissue and is time specific, so different phenotypes are produced (Fraga 
et al., 2005; Greally, 2011; Thompson et al., 2010). 
Further work is needed in order to establish regulation marks in different genomic contexts, 
since its understanding remains elusive. Fortunately, considerable insights have been 
gained and, thus far, techniques improved especially in whole-genome methylation that 
describes the association of epigenetic changes with exposure to EDCs in cells. 
In this review, we focused on DNA methylation, since manipulation of methylation patterns 
is often lethal. Moreover, findings regarding maladaptive traits confirm the relevance of 
DNA methylation in human biological development as well as other living organisms 
(Crews, 2009).  
 
3. Analysis of epigenetic mechanisms through DNA methylation  
 
The epigenetic and epigenome regulation has been elucidated through the genes implicated 
in endocrine signaling such as DNA methylation (Fig. 1) (Zhang & Ho, 2014). Although 
several epigenetic regulators are present, most studies usually focus on cytosine 
methylation assays, which can be quantitative strand-specific, and allow nucleotide 
resolution (Suzuki et al., 2010); also, could involve methylation on a locus-specific or 
genome-wide scale (Shen & Waterland, 2007). Almost all techniques require DNA 
pretreatment for enrichment of methylated DNA. These approaches are based on restriction 
enzymes (REs), bisulfite conversion, and affinity enrichment, and some combinations 
thereof (Laird, 2010). 
 
RE assays use methylation-dependent REs and are currently the most commonly used 
methods for epigenetic analysis. The coverage and resolution depend on the recognition 
sequences throughout the genome. However, RE assays can only analyze CpGs sites within 
the RE action range; thus, incomplete digestion may cause false positives. Differential 
methylation hybridization (DMH) is an example of an epigenomic analytical technique 
based on RE assays. In DMH, genomic DNA is fragmented with a methylation-
independent RE. Then, these fragments are ligated with adaptors. Next, the DNA is 
digested with the methylation-sensitive enzyme BstUI; it is then, it is PCR-amplified, 
labeled, and co-hybridized to CpG island microarrays (Yan et al., 2009). 
 
Bisulfite conversion is an accurate and reproducible technique that takes advantage of the 
deamination capacity of unmethylated cytosines by sodium bisulfite, and its later 
conversion to uracil or thymine at higher rates than methylated cytosines. This method 
represents the gold standard for detecting changes in DNA methylation due to a nucleotide-
level resolution and detection of methyl-specific single-stranded DNA (ssDNA) as a 
conversion or simple overtreatment. Some sequencing methods based on bisulfite 
conversion include bisulfite sequencing (BS), pyrosequencing, and combined bisulfite 
restriction analysis (COBRA). 
  
In the BS method, bisulfite-treated DNA is PCR-amplified with methylation-independent 
primers (methylation-specific PCR or MSP) and size-fractionated via gel electrophoresis 
(Darst et al., 2010; Herman et al., 1996). The products purified by PCR were cloned into 
Escherichia coli, and five to ten individual clones were sequenced. The Infinium 
Methylation Assay is a commercial example of this approach (Dedeurwaerder et al., 2011). 
COBRA is a variation of BS, and it combines bisulfite conversion, amplification PCR, and 
RE digestion with BstUI (Xiong & Laird, 1997). In the pyrosequencing method, bisulfite-
modified DNA is amplified with the enzyme DNA polymerase and then sequenced with 
specific primers. During the formation of the complementary DNA strand, pyrophosphate 
(PPi) is released, forming adenosine triphosphate (ATP), which supplies the energy to 
produce a luciferase–luciferin–adenosine monophosphate (AMP) complex. In the presence 
of oxygen, this complex showed a proportional light signal to ATP concentration and, 
consequently, to PPi. (Colella et al., 2003; Tost et al., 2003). Some companies have 
developed assays for pyrosequencing such as PyroMark CpG Assays (England & 
Pettersson, 2005). 
Assays involving affinity for enrichment methylated regions are based on the use of 
specific antibodies against 5-methylcytosine (5meC) to recover ssDNA, or the use of 
methyl-binding proteins to enrich methylated DNA. As this technique does not require RE 
digestion or bisulfite conversion, it does not provide information at the nucleotide level. 
Moreover, it requires large quantities of input genomic DNA and intensive labor, which can 
limit the processing of large number of samples. However, low quantities of input DNA can 
be recovered by amplification methods. The efficiency of coverage and resolution depends 
on the genomic distribution of potential affinity targets (methyl-cytosine density) and 
subsequent approaches (array composition or sequencing platform). Methylated DNA 
immunoprecipitation (MeDIP) and Methylated CpG Island Recovery assay (MIRA) are 
based on enrichment assays. In MeDIP, the DNA is sheared through sonication, denatured, 
and immunoprecipitated with an antibody against 5meC. Then, the methylated DNA is 
analyzed by microarrays or sequencing (Weber et al., 2005). MIRA assays involve the 
digestion of DNA with either MseI enzyme or sonication. Then, the sheared DNA is bound 
to an adaptor and incubated with MBD2b/MBD3L1 proteins. Finally, the enriched DNA is 
amplified and analyzed by sequencing or microarrays (Rauch & Pfeifer, 2005). 
 
Sequence-based analysis is more flexible and powerful as it allows the analysis of allele-
specific DNA methylation and requires less input DNA. Epigenetic strategies for locus-
specific methylation analysis includes a wide range of assays, for example, BS (BSPP, 
bisulfite padlock probes), methylation-specific PCR (MSP), amplification of 
intermethylated sites (AIMS), COBRA, MeDIP-PCR, methylation-sensitive melting curve 
analysis (MS-MCA), methylation-sensitive high-resolution melting (MS-HRM), 
methylation-specific fluorescent amplicon generation (MS-FLAG), sensitive melting 
analysis after real-time methylation-specific PCR (SMART-MSP), methylation-sensitive 
arbitrarily primed PCR (MS-AP-PCR), and combination of methylated DNA precipitation 
and methylation-sensitive restriction enzymes (COMPARE-MS). New technologies have 
transformed small or individual loci studies into global or genome-wide studies. 
 
Genome-wide epigenetic studies include microarrays and sequencing technologies, which 
are actively used for high-resolution mapping of the chromatin structure and DNA 
methylation (Boyle et al., 2008). To study a candidate gene, targeting their promoter is 
usually the simplest approach. Candidate genes are mostly selected for their function, 
phenotype effect, or differential expression compared to a control group (Levenson & 
Malmikov, 2012). The advantages of this approach are less time and cost; moreover, it is a 
quantitative assay providing comprehensive and unbiased insights (Greally, 2011). 
 
Of all epigenetic modifications, DNA methylation is most widely studied, due to its 
heritable nature, stability, and ease of measurement. Consequently, the majority of studies 
on the epigenetic effects of EDCs focus on these modifications. Table 1 describes some of 
the techniques already mentioned, as well as their respective advantages and limitations. 
Many of these analytical techniques involve high-cost instrumentation, highly trained 
operators, a time-consuming detection process, and complex pretreatment steps. 
Environmental epigenomics is an emerging field, and its main goal is developing rapid 
detection technologies and accurate epigenome-wide assessment methods (Jirtle & Skinner, 
2007). Further work is needed to evaluate the epigenetic effects of exposure to EDCs. In 
particular, genome-wide assays will play an important role in findings of methylation 
patterns, profiles, or levels, including imprinted genes and their relationship with emerging 
pollutants in the environment. Platform development and cost reduction of genomic 
technologies can promote further exploration of induced epigenetic alterations due to 
EDCs. Experimental data should be analyzed and integrated into biological systems 
through computational epigenomics to understand epigenetic regulatory mechanisms. In 
addition, the insights obtained can lead to novel approaches for EDC detection and 
environmental monitoring, including valid analytical methodologies and portable devices 
such as biosensors. 
 
4. Conclusions 
Chemical compounds found in pharmaceutical drugs, personal care products, food 
additives, and food containers interfere with endocrine systems since are involved in 
diseases such as prostate and breast cancer, metabolic diseases, and effects on the human 
reproductive, thyroid, cardiovascular, and neuroendocrinology systems. These endocrine-
disrupting chemicals (EDCs) are not wide regulated, and the documentation of their 
environmental effects is poor. 
Identification, detection and treatment of novel EDCs should be founded on their long-term 
effects in organisms as well as the environmental impact beyond the conventional analysis 
of accumulation, distribution, metabolism, or excretion. In this regard, environmental 
matrices can be measured in terms of general epigenetic activity due to a gene expression 
changes occurs in response to ambient factors and can inherit potential adverse alterations 
underlying the genome. The changes in gene expressions could be determined by DNA 
methylation and chromatin modifications.  
The epigenetic and epigenome regulation has been studied through the genes involved in 
endocrine signaling and their relationship with emerging pollutants in the environment. 
DNA methylation is the most studied, due to its heritable nature, stability, and ease of 
measurement. Analytical techniques are based on restriction enzymes (REs), bisulfite 
conversion, and affinity enrichment.  
Data science as well as cost reduction of genomic technologies will stimulate the 
understanding of the EDCs role on epigenetic regulatory mechanisms. In addition, the 
insights obtained could lead to novel approaches for EDC detection and environmental 
monitoring, including valid analytical methodologies and portable devices such as 
biosensors. 
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Figure 1. Conversion reaction of DNA unmethylated and methylated by bisulfite.  
A) Conversion chemistry. Bisulfite conversion is the most widely used technique for 
studying DNA methylation; the reaction occurs under harsh conditions (low pH/high 
temperature). 
B) Bisulfite conversion. Only unmethylated cytosines are converted to uracil and 
subsequently to thymine during polymerase chain reaction (PCR) amplification. 
Methylated and unmethylated cytosines can therefore be detected by comparing 
bisulfite-converted DNA to original untreated genomic DNA (Adapted from Kristensen 
& Hansen, 2009) 
 
Table 1. Comparison of analytical techniques used to evaluate the epigenetic effects of EDCs. 
Technique Description 
DNA 
Treatmen
t 
Advantage Limitations Reference 
Differential 
Methylation 
Hybridization 
(DMH) 
- Methylation-independent 
restriction enzyme that 
undergoes adaptor ligation.  
- DNA digested with 
methylation-sensitive 
enzyme BstUI. 
- PCR-amplified. 
- Labeled system. 
- Co-hybridized to CpG island 
microarrays. 
Restriction 
enzyme 
- High representation of CpG 
islands as they contain 
cleavage sites. 
- High-throughput for site-
specific detection 
- Gene precise 
- Does not allow discrimination for 
allele-specific methylation. 
- Low representation of CpG non-
enriched genomic regions. 
- Depends on represented microarray 
sequences. 
 
Yan et al., 
(2009);  
Alworth, 
(2002) 
Methylation-
specific PCR 
(MSP) 
- DNA modification by 
sodium bisulfite. 
- Reaction of cytosines to 
uracil only in unmethylated 
regions.  
- Amplification of methylated 
and unmethylated DNA with 
specific primers. 
 
Bisulfite 
conversion 
- Assessment of CpG site 
methylation status within CpG 
island. 
- Requires small quantities of 
DNA. 
- Sensitive to 0.1% methylated 
alleles of CpG island locus 
- Eliminates false-positive 
results inherent to RE-based 
PCR.  
- Distinction of methylated from 
unmethylated cytosine is dependent on 
sodium bisulfite treatment. 
- Requires optimization (lack sensitivity 
at low reaction temperatures). 
- Requires an appropriate negative 
control. 
- Not a quantitative method. 
Herman et al., 
(1996); 
Anway et al., 
(2005); 
Dolinoy et al., 
(2007)  
Technique Description 
DNA 
Treatmen
t 
Advantage Limitations Reference 
Ligation-
mediated PCR 
(LM-PCR) 
- Methylated DNA is cleaved 
with enzymes or chemicals.  
- A gene-specific 
oligonucleotide primer is 
used for primer extension,  
- Linker ligation and PCR are 
performed.  
Restriction 
enzyme or 
methylatio
n-specific 
strategy  
(e.g., 
DMA–
piperidine) 
- High-magnitude whole-
genome amplification tool. 
- Enables amplification of PCR 
fragments irrespective of the 
genomic sequence. 
- Pretreatment step for MIRA, 
MeDIP, and sequencing. 
- Restriction endonuclease 
accessibility data from 
chromatin templates in limited 
quantity. 
- Inefficient using blunt ends in the 
adaptor – ligation. 
- Potentially causes bias towards GC-
poor regions. 
- Relatively short stretch of sequence 
(usually <200 bp) that can be analyzed 
per reaction. 
- Multiple steps required. 
 
Mueller and 
Wold, (1989); 
Edinger et al., 
(2013) 
 
Methylated 
DNA Immuno-
precipitation 
(MeDIP) 
- DNA sequential treatment: 
sonication, denaturation, and 
immunoprecipitation 
(antibody against 5-
methylcystidine).  
- Methylated DNA is analyzed 
via sequencing or 
microarrays. 
Affinity 
enrichment 
- Sensibility to methylation 
high density. 
- Provides genome-wide 
methylation maps. 
- Allows tissue-specific 
differentially methylated 
region evaluation. 
- Depending on shearing size resolution 
and antibody quality and specificity. 
- Enrichment efficiency significantly 
lower in regions with low CpG 
content. 
- DNA needs to be single stranded 
(difficult for regions of high CpG). 
Weber et al., 
(2005); 
Guerrero-
Bosagna et al., 
(2013) 
Bisulfite 
Sequencing 
- PCR amplification of 
bisulfite-treated DNA. 
- Fractioning by gel 
electrophoresis. 
Bisulfite 
conversion 
- Quantitative DNA 
methylation analysis. 
- Single CpG resolution. 
- Detection of strand-specific 
methylation. 
- Whole-genome approach. 
- Labor intensive. 
- Depends on nested PCR primers to 
amplify the fragment of interest. 
- Difficult for DNA with suboptimal 
integrity. 
Darst et al., 
(2010) 
Technique Description 
DNA 
Treatmen
t 
Advantage Limitations Reference 
Pyrosequencin
g 
- Bisulfite modification of 
DNA 
- Amplification with DNA 
polymerase and sequencing 
primers.  
- Formation of luciferase–
luciferin–AMP complex by 
release of ATP: light signal 
is proportional to the amount 
of available ATP and thus 
PPi. 
Bisulfite 
conversion 
- High-throughput for site-
specific detection 
- Accurate and high resolution 
for methylation variable 
positions. 
- Methylation in most types of 
repetitive sequences. 
- High instrumentation costs. 
- Limitation by the length of the 
sequence read and number of CpGs 
analyzed in one reaction. 
 
Colella et al., 
(2003); 
Tost et al., 
(2003);  
England & 
Pettersson 
(2005); 
Gore et al., 
(2011) 
 
